利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

51 条记录 (耗时 0.042 秒)

    Oxazole derivatives
    45.
    发明授权
    Oxazole derivatives 失效
    恶唑衍生物

    公开(公告)号：US07348349B2

    公开(公告)日：2008-03-25

    申请号：US11183360

    申请日：2005-07-18

    申请人： Alfred Binggeli ,  Markus Boehringer ,  Uwe Grether ,  Hans Hilpert ,  Georges Hirth ,  Hans-Peter Maerki ,  Markus Meyer ,  Peter Mohr ,  Fabienne Ricklin

    发明人： Alfred Binggeli ,  Markus Boehringer ,  Uwe Grether ,  Hans Hilpert ,  Georges Hirth ,  Hans-Peter Maerki ,  Markus Meyer ,  Peter Mohr ,  Fabienne Ricklin

    IPC分类号： A61K31/421 ,  C07D263/30

    CPC分类号： C07D263/32

    摘要： The present invention relates to compounds of formula (I) wherein wherein R1, R2, R3, R4, R5, R6 and n are as described herein. The compounds of the present invention can be used as medicaments for the treatment and/or prevention of diseases which are modulated by PPARα and/or PPARγ agonists. Examples of such diseases are diabetes, particularly non-insulin dependent diabetes mellitus, elevated blood pressure, increased lipid and cholesterol levels, atherosclerotic diseases, metabolic syndrome, endothelial dysfunction, procoagulant state, dyslipidemia, polycystic ovary syndrome, inflammatory diseases (such as e.g. crown disease, inflammatory bowel disease, collitis, pancreatitis, cholestasis/fibrosis of the liver, and diseases that have an inflammatory component such as e.g. Alzheimer's disease or impaired/improvable cognitive function) and proliferative diseases.

    摘要翻译： 本发明涉及式（I）化合物，其中R 1，R 2，R 3，R 4， R 5，R 5，R 6和n如本文所述。 本发明的化合物可用作治疗和/或预防由PPARα和/或PPARγ激动剂调节的疾病的药物。 这些疾病的例子包括糖尿病，特别是非胰​​岛素依赖性糖尿病，升高的血压，升高的脂质和胆固醇水平，动脉粥样硬化疾病，代谢综合征，内皮功能障碍，促凝血状态，血脂异常，多囊卵巢综合征，炎性疾病（例如冠 疾病，炎性肠病，结肠炎，胰腺炎，胆汁郁积/肝脏纤维化，以及具有诸如阿尔茨海默病和受损/可改善的认知功能等炎症成分的疾病）和增殖性疾病。

    Novel oxazole derivatives
    49.
    发明申请
    Novel oxazole derivatives 失效
    新型恶唑衍生物

    公开(公告)号：US20050267180A1

    公开(公告)日：2005-12-01

    申请号：US11183360

    申请日：2005-07-18

    申请人： Alfred Binggeli ,  Markus Boehringer ,  Uwe Grether ,  Hans Hilpert ,  Georges Hirth ,  Hans-Peter Maerki ,  Markus Meyer ,  Peter Mohr ,  Fabienne Ricklin

    发明人： Alfred Binggeli ,  Markus Boehringer ,  Uwe Grether ,  Hans Hilpert ,  Georges Hirth ,  Hans-Peter Maerki ,  Markus Meyer ,  Peter Mohr ,  Fabienne Ricklin

    IPC分类号： A61K31/421 ,  A61P3/10 ,  C07D263/32

    CPC分类号： C07D263/32

    摘要： The present invention relates to compounds of formula (I) wherein wherein R1, R2, R3, R4, R5, R6 and n are as described herein. The compounds of the present invention can be used as medicaments for the treatment and/or prevention of diseases which are modulated by PPARα and/or PPARγ agonists. Examples of such diseases are diabetes, particularly non-insulin dependent diabetes mellitus, elevated blood pressure, increased lipid and cholesterol levels, atherosclerotic diseases, metabolic syndrome, endothelial dysfunction, procoagulant state, dyslipidemia, polycystic ovary syndrome, inflammatory diseases (such as e.g. crown disease, inflammatory bowel disease, collitis, pancreatitis, cholestasis/fibrosis of the liver, and diseases that have an inflammatory component such as e.g. Alzheimer's disease or impaired/improvable cognitive function) and proliferative diseases.

    摘要翻译： 本发明涉及式（I）化合物，其中R 1，R 2，R 3，R 4， R 5，R 5，R 6和n如本文所述。 本发明的化合物可用作治疗和/或预防由PPARα和/或PPARγ激动剂调节的疾病的药物。 这些疾病的例子包括糖尿病，特别是非胰​​岛素依赖性糖尿病，升高的血压，升高的脂质和胆固醇水平，动脉粥样硬化疾病，代谢综合征，内皮功能障碍，促凝血状态，血脂异常，多囊卵巢综合征，炎性疾病（例如冠 疾病，炎性肠病，结肠炎，胰腺炎，胆汁郁积/肝脏纤维化，以及具有诸如阿尔茨海默病和受损/可改善的认知功能等炎症成分的疾病）和增殖性疾病。